Qisda Framtida tillväxt
Future kriterier kontrolleras 0/6
Vi har för närvarande inte tillräcklig analytikertäckning för att förutsäga tillväxt och intäkter för Qisda.
Viktig information
n/a
Tillväxttakt i vinsten
n/a
Tillväxttakt för EPS
| Tech vinsttillväxt | 21.6% |
| Intäkternas tillväxttakt | n/a |
| Framtida avkastning på eget kapital | n/a |
| Bevakning av analytiker | Low |
| Senast uppdaterad | 14 Apr 2026 |
Senaste uppdateringarna om framtida tillväxt
Recent updates
Analysuppdatering • Apr 02
2352: Steady Fair Value And Refined Assumptions Will Support Future Upside
Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.Analysuppdatering • Mar 19
2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside
Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.Analysuppdatering • Mar 04
2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price
Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.Analysuppdatering • Feb 18
2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price
Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Ny analys • Feb 06
AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround
Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?Analysuppdatering • Feb 03
2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price
Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.Analysuppdatering • Jan 19
2352: Stable Long Term Assumptions Will Support A Higher Future Share Price
Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.Analysuppdatering • Jan 05
2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price
Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.Analysuppdatering • Dec 14
2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance
Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.Analysuppdatering • Nov 29
2352: Lower Profit Margins Will Give Way To Future Share Price Upside
Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.Analysuppdatering • Nov 15
2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside
Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.Analysuppdatering • Nov 01
2352: Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.Analysuppdatering • Oct 17
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.Analysuppdatering • Oct 03
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.Analysuppdatering • Sep 17
Investments In AIoT And Medical Services Will Boost Future Profitability
The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.Analysuppdatering • Sep 02
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
Ny analys • Feb 21
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.Analysartikel • Mar 12
Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture
The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...Analysartikel • Mar 09
Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Analysartikel • Feb 29
Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysartikel • Mar 15
Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?
Dividend paying stocks like Qisda Corporation ( TPE:2352 ) tend to be popular with investors, and for good reason...Analysartikel • Feb 26
Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Qisda's (TPE:2352) stock is up by a considerable 32% over the past three months. However, we decided to pay attention...Analysartikel • Feb 08
These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysartikel • Jan 24
Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...Analysartikel • Jan 09
Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...Analysartikel • Dec 25
We Like These Underlying Trends At Qisda (TPE:2352)
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Prognoser för vinst- och omsättningstillväxt
| Datum | Intäkter | Intäkter | Fritt kassaflöde | Kassaflöde från rörelsen | Genomsnittligt Antal analytiker |
|---|---|---|---|---|---|
| 12/31/2026 | 217,744 | 2,696 | -4,932 | 2,252 | 1 |
| 12/31/2025 | 207,905 | 1,143 | 3,313 | 9,106 | N/A |
| 9/30/2025 | 209,844 | 1,281 | 3,126 | 8,900 | N/A |
| 6/30/2025 | 208,105 | 2,083 | 22 | 5,721 | N/A |
| 3/31/2025 | 204,499 | 2,390 | -311 | 5,367 | N/A |
| 12/31/2024 | 201,666 | 2,164 | -2,480 | 3,301 | N/A |
| 9/30/2024 | 198,233 | 2,399 | -2,058 | 3,673 | N/A |
| 6/30/2024 | 197,809 | 2,548 | -793 | 4,615 | N/A |
| 3/31/2024 | 200,063 | 2,909 | 1,328 | 7,123 | N/A |
| 12/31/2023 | 203,595 | 2,976 | 8,276 | 13,611 | N/A |
| 9/30/2023 | 209,045 | 2,922 | 16,446 | 22,534 | N/A |
| 6/30/2023 | 218,734 | 8,084 | 12,293 | 18,883 | N/A |
| 3/31/2023 | 229,417 | 8,042 | 2,746 | 9,024 | N/A |
| 12/31/2022 | 239,837 | 8,252 | -8,195 | -1,191 | N/A |
| 9/30/2022 | 245,593 | 8,876 | -15,082 | -7,758 | N/A |
| 6/30/2022 | 242,734 | 3,907 | -16,648 | -9,963 | N/A |
| 3/31/2022 | 235,923 | 6,730 | -12,280 | -5,105 | N/A |
| 12/31/2021 | 225,961 | 8,308 | -4,599 | 2,115 | N/A |
| 9/30/2021 | 221,223 | 9,073 | -4,171 | 2,174 | N/A |
| 6/30/2021 | 215,716 | 9,724 | 4,015 | 10,595 | N/A |
| 3/31/2021 | 203,405 | 6,868 | 7,648 | 13,242 | N/A |
| 12/31/2020 | 191,702 | 4,988 | 9,613 | 14,569 | N/A |
| 9/30/2020 | 180,430 | 3,861 | 7,961 | 11,683 | N/A |
| 6/30/2020 | 171,539 | 2,825 | 8,624 | 11,687 | N/A |
| 3/31/2020 | 169,101 | 2,918 | 9,040 | 11,709 | N/A |
| 12/31/2019 | 169,754 | 3,575 | 5,820 | 8,475 | N/A |
| 9/30/2019 | 166,279 | 3,981 | N/A | 6,572 | N/A |
| 6/30/2019 | 163,148 | 4,166 | N/A | 7,005 | N/A |
| 3/31/2019 | 159,983 | 3,927 | N/A | 7,073 | N/A |
| 12/31/2018 | 155,783 | 4,035 | N/A | 8,958 | N/A |
| 9/30/2018 | 150,516 | 4,412 | N/A | 8,414 | N/A |
| 6/30/2018 | 146,001 | 4,497 | N/A | 7,913 | N/A |
| 3/31/2018 | 140,830 | 5,058 | N/A | 4,389 | N/A |
| 12/31/2017 | 136,862 | 5,291 | N/A | 336 | N/A |
| 9/30/2017 | 134,025 | 5,475 | N/A | 4,681 | N/A |
| 6/30/2017 | 130,853 | 5,626 | N/A | 2,228 | N/A |
| 3/31/2017 | 129,476 | 5,059 | N/A | 5,254 | N/A |
| 12/31/2016 | 129,554 | 4,342 | N/A | 7,948 | N/A |
| 9/30/2016 | 129,484 | 2,998 | N/A | 7,144 | N/A |
| 6/30/2016 | 130,750 | 2,141 | N/A | 6,600 | N/A |
| 3/31/2016 | 132,439 | 2,063 | N/A | 7,470 | N/A |
| 12/31/2015 | 133,102 | 2,169 | N/A | 5,250 | N/A |
| 9/30/2015 | 134,323 | 2,727 | N/A | 1,540 | N/A |
| 6/30/2015 | 135,974 | 3,194 | N/A | 2,112 | N/A |
Analytiker Framtid Tillväxt Prognoser
Intäkter kontra sparande: Otillräcklig data för att avgöra om 2352 s prognostiserade vinsttillväxt ligger över sparkvoten ( 1.3% ).
Resultat vs marknad: Otillräcklig data för att avgöra om 2352 s intäkter förväntas växa snabbare än marknaden för TW
Höga tillväxtresultat: Otillräcklig data för att avgöra om 2352 s intäkter förväntas växa avsevärt under de kommande 3 åren.
Intäkt vs marknad: Otillräcklig data för att avgöra om 2352 s intäkter förväntas växa snabbare än marknaden för TW.
Hög tillväxtintäkter: Otillräcklig data för att avgöra om intäkterna från 2352 förväntas växa snabbare än 20% per år.
Tillväxtprognoser för vinst per aktie
Framtida avkastning på eget kapital
Framtida ROE: Otillräcklig data för att avgöra om 2352 s avkastning på eget kapital förväntas bli hög om tre år
Upptäck tillväxtföretag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/07 21:47 |
| Aktiekurs vid dagens slut | 2026/05/07 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Qisda Corporation bevakas av 6 analytiker. 1 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Nicholas Teo | CLSA |
| Joey Cheng | Goldman Sachs |
| null null | KGI Securities Co. Ltd. |